Drugs / Carteolol
Carteolol
also known as
ABBOTT-43326 · Carteolol hcl · CARTEOLOL HYDROCHLORIDE · Cartrol · Mikelan · NSC-300906 · Ocupress · OPC-1085 · +1 more
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Filed glaucoma 1 milestone | |||||
| Filed | Japan (PMDA) | — | glaucoma | 2015-10-01 | “submitted a new drug application to the Japanese Ministry of Health, Labour and Welfare for regulatory approval of, carteolol hydrochloride/ latanoprost” otsuka.co.jp ↗ |
| Approved Indication not stated 1 milestone | |||||
| Approved | US (FDA) | CARTROL | — | 1988-12-28 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT00972426 | Oct 2009 → Aug 2010 | glaucoma | Taiwan Otsuka Pharm. Co., Ltd | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT02108288 Comparator | Apr → May 2014 | glaucoma, ocular hypertension | Otsuka Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT02105285 Comparator | Apr 2014 → Jan 2015 | glaucoma, ocular hypertension | Otsuka Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2015-10-01 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Regulatory New Drug Application for Carteolol Hydrochloride/ Latanoprost, a Novel Combined Ophthalmic Solution, Submitted in Japan for the Treatment of Glaucoma and Ocular Hypertension otsuka.co.jp ↗
Otsuka Pharmaceutical Co., Ltd., announced that it has submitted a new drug application to the Japanese Ministry of Health, Labour and Welfare for regulatory approval of, carteolol hydrochloride/ latanoprost, a novel combined ophthalmic solution. |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2015-10-01 | Otsuka Pharmaceutical Development & Commercialization, Inc. | New Drug Application for Carteolol Hydrochloride/ Latanoprost, a Novel Combined Ophthalmic Solution, Submitted in Japan for the Treatment of Glaucoma and Ocular Hypertension otsuka.co.jp ↗ |
Evidence & citations 12 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | carteolol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00972426 ↗ |
| Known as | ABBOTT-43326 | ChEMBL registry synonym — accepted as the source's own label CHEMBL839 ↗ |
| Known as | Carteolol hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL839 ↗ |
| Known as | CARTEOLOL HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL839 ↗ |
| Known as | Cartrol | ChEMBL registry synonym — accepted as the source's own label CHEMBL839 ↗ |
| Known as | Mikelan | “carteolol (Mikelan), timolol (Timoptol), latanoprost (Xalatan)” NCT00972426 ↗ |
| Known as | NSC-300906 | ChEMBL registry synonym — accepted as the source's own label CHEMBL839 ↗ |
| Known as | Ocupress | ChEMBL registry synonym — accepted as the source's own label CHEMBL839 ↗ |
| Known as | OPC-1085 | ChEMBL registry synonym — accepted as the source's own label CHEMBL839 ↗ |
| Known as | Teoptic | ChEMBL registry synonym — accepted as the source's own label CHEMBL839 ↗ |
| Modality | Small molecule | — CHEMBL839 ↗ |
| Route | Topical | “Mikelan LA eye drops 2%” NCT00972426 ↗ |